세계의 펨테크 시장 - 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Femtech Market was valued at USD 60.2 billion in 2024 and is projected to expand at a CAGR of 16% between 2025 and 2034. Femtech, short for female technology, focuses on developing innovative products, services, and platforms that address women's unique healthcare needs. These include solutions for fertility, pregnancy, reproductive health, menopause, sexual wellness, and general well-being. Growing reliance on digital technologies to manage women's health, especially in developed nations, has significantly propelled market growth.

Increasing chronic conditions such as cancer, diabetes, hypertension, and mental health issues among women are fueling the demand for personalized, tech-driven healthcare. Femtech offers tailored tools that assist women in managing complex health challenges, further boosting the market. The ongoing rise in awareness around women-centric health issues and the development of wearable and mobile health devices are driving the need for accessible and targeted solutions. The integration of advanced technology into everyday healthcare for women has encouraged more women to adopt digital platforms, creating strong market momentum.

In terms of type, the femtech market was estimated at USD 60.2 billion in 2024, with the product segment contributing USD 11.5 billion and expected to register a 13.8% growth rate from 2025 to 2034. Increasing demand for personalized healthcare solutions and rapid advancements in wearable devices and mobile health technologies are enhancing product adoption. Rising awareness about pregnancy complications and the need for innovative tools for monitoring and managing women's health further support the market outlook. On the application front, femtech is divided into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and others.

The reproductive health segment led the market with USD 26.4 billion in revenue in 2024, capturing a 43.9% share. Growing recognition of fertility, pregnancy, menstruation, and menopause-related health concerns, coupled with rising openness in discussing these issues, has increased demand for specialized reproductive health solutions. The incorporation of advanced wearable devices, mobile apps, and telemedicine has transformed reproductive health management, pushing the market forward.

Based on end use, the market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and others. The direct-to-consumer segment accounted for USD 19.5 billion in 2024, driven by the rising preference for personalized healthcare tools accessible from home. Women are increasingly opting for products that address sensitive health needs while ensuring privacy and convenience. Femtech companies are also leveraging user data to create more effective and tailored solutions, boosting customer satisfaction and market penetration.

Regionally, North America generated USD 19.5 billion in revenue in 2024, with the U.S. accounting for 89.2% of this share, largely due to a growing focus on women's health and increasing demand for accessible and affordable solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Usage of digital technology to manage women health in developed countries
    • 3.2.1.2 Improving access to women care in remote areas
    • 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
    • 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
    • 3.2.1.5 Growing investments in femtech industry
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of awareness about femtech products and applications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Products
• 5.3 Software
• 5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Reproductive health
  • 6.1.1 Menstrual cycle and fertility
  • 6.1.2 Menopause
• 6.2 Pregnancy and nursing care
• 6.3 Pelvic and uterine healthcare
• 6.4 General healthcare and wellness
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Direct-to-consumer
• 7.3 Hospitals
• 7.4 Fertility clinics
• 7.5 Surgical centers
• 7.6 Diagnostic centers
• 7.7 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia

Chapter 9 Company Profiles

• 9.1 BioWink GmbH
• 9.2 Athena Feminine Technologies
• 9.3 Conceivable, Inc
• 9.4 HeraMED
• 9.5 Elvie
• 9.6 iSono Health
• 9.7 Nuvo Cares
• 9.8 Minerva Surgical
• 9.9 Prelude
• 9.10 Sustain Natural
• 9.11 Sera Prognostics
• 9.12 Univfy
• 9.13 Totohealth